Search results
Results from the WOW.Com Content Network
Also known as “sundowner’s syndrome,” sundowning is a set of symptoms or behaviors that can be seen in some people with Alzheimer’s disease and dementia, according to the Alzheimer’s ...
The term sundowning was coined by nurse Lois K. Evans in 1987 due to the association between the person's increased confusion and the setting of the sun. [2] [3] For people with sundown syndrome, a multitude of behavioral problems begin to occur and are associated with long-term adverse outcomes.
In older people with dementia, its use increases the risk of death. [11] Use in the third trimester of pregnancy may result in a movement disorder in the baby for some time after birth. [ 11 ] Quetiapine is believed to work by blocking a number of receptors, including those for serotonin and dopamine .
Elopement, or unattended wandering that goes out of bounds, is a special concern for caregivers and search and rescue responders. Wandering (especially if combined with sundowning) can result in the person being lost outdoors at night, dressed inappropriately, and unable to take many ordinarily routine steps to ensure his or her personal safety and security.
An estimated 10 to 20 percent of people age 65 or older with MCI will develop recognizable or diagnosable dementia within a year, according to the National Institute on Aging.
(Age 65 is when people are officially considered "older" adults.) ... This can also be caused by hormones, nutritional deficiencies, autoimmune disorders and medications, Friedman adds.
Donepezil, sold under the brand name Aricept among others, is a medication used to treat dementia of the Alzheimer's type. [3] [4] [8] It appears to result in a small benefit in mental function and ability to function. [9] Use, however, has not been shown to change the progression of the disease. [10] Treatment should be stopped if no benefit ...
A prolonged-release 2 mg oral formulation of melatonin sold under the brand name Circadin is approved for use in the European Union in the short-term treatment of insomnia in people age 55 and older. [11] [29] [8] Melatonin is also available as an over-the-counter dietary supplement in many countries. It is available in both immediate-release ...